Expression data from cerebral tumors of WHO grade II and III

LHA-ID
7Q0CFRJM3Y-6
Motivation

The goal of this study was to improve the stratification of patients with grade II/III gliomas to prognostic groups by molecular profiling.

Description
Molecular profiling of cerebral gliomas distinguishes biologically distinct tumor groups and provides prognostically relevant information beyond histological classification and IDH1/2 mutation status. We performed microarray-based genome- and transcriptome-wide molecular profiling of primary tumor samples from 137 patients with cerebral gliomas, 61 WHO grade II and 76 WHO grade III tumors.
Publication Date
Contact
Hans Binder
Contact Institution

IZBI
Härtelstr. 16-18
04107 Leipzig

Version Number
1.0
Sample Size
N=137; n=64 Grad II n = 76 Grad III
Data Level
Level 1, 2, 3
Development Environment
oposSOM
Programing Language
R
Analysis Type
Evaluation Pipeline
Library Type
Tissue Type
Human Disease Ontology Concept